Skip to main content
Equibles

RAYMOND JAMES FINANCIAL INC

Position in DSGN — Design Therapeutics, Inc.

CIK 720005 ST. PETERSBURG, FL
Back to DSGN Full portfolio

Position in DSGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,004,398
+$850,501 QoQ
Shares Held
138,521
+27.7% QoQ
Ownership
0.221%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#39
of 136 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority Sole 11% Shared 0% None 89%

Common Shares in DSGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RAYMOND JAMES FINANCIAL INC holds $1,702,332,948 across 201 Biotechnology names. DSGN ranks #77 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 556,876 $276,617,014
2 ALNY
Alnylam Pharmaceuticals, Inc.
 392,799 $118,244,281
3 REGN
Regeneron Pharmaceuticals, Inc.
 172,896 $107,807,571
4 RPRX
Royalty Pharma plc
 1,599,881 $89,705,325
5 INSM
INSMED Inc
 660,601 $70,433,276
6 KRYS
Krystal Biotech, Inc.
 158,675 $58,974,733
7 JAZZ
Jazz Pharmaceuticals plc
 228,645 $55,096,584
8 EXEL
Exelixis, Inc.
 941,571 $51,230,875

All Filings in DSGN

Export CSV
3 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,004,398 138,521
2026-03-31 $1,153,897 108,449
2025-12-31 $1,029,576 109,763